Detalhe da pesquisa
1.
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Am J Kidney Dis
; 83(3): 340-349.e1, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777061
2.
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Am J Kidney Dis
; 83(5): 588-600.e1, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151224
3.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
J Am Soc Nephrol
; 34(6): 955-968, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918388
4.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
5.
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.
PLoS Med
; 18(7): e1003691, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260595
6.
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
PLoS Med
; 18(6): e1003668, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166370
7.
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.
PLoS Med
; 16(4): e1002777, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951521
8.
An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
Am J Kidney Dis
; 74(1): 56-72, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851964
9.
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
Am J Kidney Dis
; 74(3): 338-350, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027883
10.
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.
Diabetes Obes Metab
; 21(5): 1177-1190, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793466
11.
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
J Am Soc Nephrol
; 29(1): 283-294, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29030465
12.
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
J Am Soc Nephrol
; 28(9): 2729-2737, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487395
13.
Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study.
Am J Transplant
; 17(12): 3159-3171, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792681
14.
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Lancet
; 388(10060): 2629-2641, 2016 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27720497
15.
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.
J Am Soc Nephrol
; 27(6): 1811-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26567244
16.
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease.
Clin Gastroenterol Hepatol
; 14(7): 1022-1030.e4, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26844873
17.
Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.
Blood
; 123(6): 822-8, 2014 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24357725
18.
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
J Am Soc Nephrol
; 26(5): 1205-14, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25194004
19.
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.
Lancet
; 382(9903): 1485-95, 2013 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23972263
20.
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.
Blood
; 119(14): 3269-75, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289887